Remove 2019 Remove Clinic Remove Education Remove Screening
article thumbnail

Cervical Cancer Screening Differences Between Black and White Women: An Examination of HPV and Pap Test Utilization. [Screening, prevention, and health promotion]

Annals of Family Medicine

Context The introduction of the Human Papillomavirus (HPV) test and the 2012 Cervical Cancer Screening (CCS) guidelines expanded the way providers offer and interpret screening for their patients. Chi-square and odds ratios were used to detect racial differences by screening type.

Screening 130
article thumbnail

Promoting Compassionate Emergency Care for Children with Autism

PEMBlog

What you can do: Implement brief screening tools at registration to identify communication needs, sensory triggers, and calming strategies. What you can do: Incorporate ASD care into simulation scenarios, staff onboarding, and continuing education. 2019-1895L. The Journal of Clinical Psychiatry. Pediatrics.

Family 77
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

FDA Law Blog

Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 Team meetings with subject matter experts can be scheduled to discuss response strategies for deficiencies that require extensive clinical, scientific, or engineering input. 510(k) Time to MDUFA IV Decision.

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Screening for substance use and offering connections to treatment and community-based services are important strategies that clinicians can implement in their own practice today. Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group.

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. I’m part of a clinical trial that’s housed at the Lundquist Institute down at Harbor-UCLA.

article thumbnail

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

GeriPal

Summary Transcript CME Summary Weve covered psychedelics on the podcast beforefirst in 2019 with Ira Byock, where we explored their potential role in medicine , and then again in 2023 with Stacy Fischer, Brian Anderson, and Theora Cimino, focusing on the reasons to approach psychedelic use in patients with caution. James 00:32 Good afternoon.

Illness 107
article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

Are there meaningful ways of assessing loneliness and social isolation in clinical settings and connecting patients with interventions? The Listening “EAR” approach that simplifies assessment of loneliness and social isolation in clinical settings, and other practical pointers.

IT 99